Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Impact of Immunosuppressive Therapy on the Performance of Latent Tuberculosis Screening Tests in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Screening for latent tuberculosis infection (LTBI) is mandatory before commencing tumor necrosis factor (TNF)-α inhibitor use. However, the impact of immunosuppressive therapy (IST), including corticosteroids and immunomodulators, on the performance of LTBI screening in patients with inflammatory bo...

Full description

Bibliographic Details
Main Authors:	Chan Hyuk Park, Jung Ho Park, Yoon Suk Jung
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Journal of Personalized Medicine
Subjects:	interferon gamma release assay tuberculin skin test immunosuppressive therapy inflammatory bowel disease
Online Access:	https://www.mdpi.com/2075-4426/12/3/507

Similar Items

Performance of Screening Strategies for Latent Tuberculosis Infection in Patients with Inflammatory Bowel Disease: Results from the ENEIDA Registry of GETECCU
by: Sabino Riestra, et al.
Published: (2022-07-01)

Interferon-gamma assay and tuberculin skin test for screening of latent tuberculosis in patients with inflammatory bowel disease: a summarization study
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-01-01)

The Role of Interferon-Gamma Release Assays in Diagnosis of Latent Tuberculosis Infection in Children
by: Mateja Šegović, et al.
Published: (2023-01-01)

A Review on Immunological Diagnosis Methods of Tuberculosis Infection
by: M Jafari, et al.
Published: (2017-01-01)

Performance of a Rapid Strip Test for the Serologic Diagnosis of Latent Tuberculosis in Children
by: Songsri Kasempimolporn, et al.
Published: (2015-01-01)

Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance
by: Monika Szturmowicz, et al.
Published: (2021-09-01)

From Latent Tuberculosis Infection to Tuberculosis. News in Diagnosticsb (QuantiFERON-Plus)
by: Dagmara I. Borkowska, et al.
Published: (2017-03-01)

Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test
by: Yijun He, et al.
Published: (2022-12-01)

Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation
by: Peter Auguste, et al.
Published: (2016-05-01)

Comparative evaluation of QuantiFERON-TB Gold Plus for diagnosis of latent tuberculosis infection during solid organ transplantation
by: Sun Joo Yoon, et al.
Published: (2020-03-01)

Impact of sensitisation programme on screening tests for latent tuberculosis infection among health-care workers: A questionnaire-based study
by: Kanthishree Haritsa, et al.
Published: (2023-01-01)

Use of interferon-gamma release assay and tuberculin skin test in diagnosing tuberculosis in Lithuanian adults: A comparative analysis
by: Laura Tamašauskienė, et al.
Published: (2017-01-01)

Use of interferon-gamma release assay and tuberculin skin test in diagnosing tuberculosis in Lithuanian adults: A comparative analysis
by: Laura Tamašauskienė, et al.
Published: (2017-07-01)

Latent tuberculosis screening before kidney transplantation in the South of Brazil
by: Gisele Meinerz, et al.
Published: (2021-05-01)

Interferon Gamma Release Assays (IGRA) in the Diagnosis of Active Pulmonary Tuberculosis
by: Mona K. EL-Deeb, et al.
Published: (2014-06-01)

An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa
by: Elouise E. Kroon, et al.
Published: (2020-11-01)

Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study
by: Ibrahim Abubakar, et al.
Published: (2018-10-01)

Ethical evaluation of immigration screening policy for latent tuberculosis infection
by: Justin T. Denholm, et al.
Published: (2012-08-01)

Latent Tuberculosis in Health Care Workers Exposed to Active Tuberculosis in a Tertiary Care Hospital in Oman
by: Faryal Khamis, et al.
Published: (2016-07-01)

Selection of the cutoff value of the tuberculin skin test for diagnosing students who need preventive treatment: A school-based cross-sectional study
by: Peng Lu, et al.
Published: (2022-10-01)

Performance and correlation of interferon gamma release assays and tuberculin skin test in HIV-infected children and adolescents with immune reconstitution
by: Keswadee Lapphra, et al.
Published: (2020-01-01)

Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth
by: Dagnew Alemnew F, et al.
Published: (2012-08-01)

Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients
by: Maisuri Tadjuddin Chalid, et al.
Published: (2022-01-01)

Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control Strategy
by: Wenping Gong, et al.
Published: (2021-10-01)

Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
by: Kyuwon Kim, et al.
Published: (2021-05-01)

Right to Occupational Safety: Prevalence of Latent Tuberculosis Infection in Healthcare Workers. A 1-Year Retrospective Survey Carried out at Hospital of Lecce (Italy)
by: Gabriele d’Ettorre, et al.
Published: (2023-10-01)

Clinical characteristics and related influencing factors of common rheumatic diseases concomitant with tuberculosis
by: Guo Tang, et al.
Published: (2023-01-01)

Performance of two interferon-gamma release assays for tuberculosis infection screening in Kawasaki children before immunosuppressive therapy
by: Hao Chen, et al.
Published: (2023-05-01)

Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study
by: Giselle Burlamaqui Klautau, et al.
Published: (2018-11-01)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
by: Karan Sachdeva, et al.
Published: (2023-04-01)

Immunological assays in the diagnosis of tuberculosis infection at the beginning of 21st century
by: Kašiković-Lečić Svetlana, et al.
Published: (2010-01-01)

Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- γ release assay and IFN-γ-induced protein-10
by: Roxana Mansour Ghanaie, et al.
Published: (2021-02-01)

Conversion and Reversion Rates of Tuberculosis Screening Assays in Patients With Rheumatic Diseases and Negative Baseline Screening Under Long-Term Biologic Treatment
by: Konstantinos Thomas, et al.
Published: (2020-02-01)

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
by: Sara Debulpaep, et al.
Published: (2019-07-01)

Latent tuberculosis infection and screening method among close contacts in schools in Xuhui District，Shanghai from 2020 to 2022
by: ZHANG Sainan, et al.
Published: (2023-12-01)

Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination
by: P Godoy
Published: (2021-04-01)

Phenotype Definition for “Resisters” to Mycobacterium tuberculosis Infection in the Literature—A Review and Recommendations
by: Jesús Gutierrez, et al.
Published: (2021-02-01)

The Application of T.SPOT-TB Assay for Early Diagnosis of Active Tuberculosis in Chronic Kidney Disease Patients Receiving Immunosuppressive Treatment
by: Haitao Wang, et al.
Published: (2020-10-01)

Comparison of Tuberculin Skin Test result and interferon gamma response to human PPD in BCG scar positive and negative children
by: Shirin Sayyahfar, et al.
Published: (2019-04-01)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in the prison population with a positive tuberculin test: a descriptive study in a prison (Burgos, Spain)
by: Roberto Baca, et al.
Published: (2024-01-01)